Gene transfer to liver cancer cells of B7-1 plus interleukin 12 changes immunoeffector mechanisms and suppresses helper T cell type 1 cytokine production induced by interleukin 12 alone

Human Gene Therapy

Volumn 11, Issue 1, 2000, Pages 127-138

  Sun, Yonglian ^a   Qian, Cheng ^a   Peng, Dacheng ^a   Prieto, Jesús ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE THERAPY; GENE TRANSFER; HELPER CELL; IMMUNIZATION; LIVER CANCER; MOUSE; NONHUMAN; RETROVIRUS; TUMOR CELL;

ANIMALS; ANTIGENS, CD80; BASE SEQUENCE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE TRANSFER TECHNIQUES; HUMANS; IMMUNOTHERAPY; INTERFERON TYPE II; INTERLEUKIN-12; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; TH1 CELLS;

EID: 0033965355     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050016210     Document Type: Article

References (37)

1. Baskar, S., Ostrand-Rosenberg, S., Nabavi, N., Nadler, L.M., Freeman, G.J., and Glimcher, L.H. (1993). Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. U.S.A. 90, 5687-5690.
2. + tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice. J. Exp. Med. 181, 619-629.
3. Chen, L., Ashe, S., Brady, W.A., Hellström, I., Hellström, K.E., Ledbetter, J.A., McGowan, P., and Linsley, P.S. (1992). Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD8 and CTLA-4. Cell 71, 1093-1102.
4. Chen, L., McGowan, P., Ashe, S., Johnston, J., Li, Y., Hellström, I., and Hellström, K.E. (1994). Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J. Exp. Med. 179, 523-532.
5. Chong, H., Hutchinson, G., Hart, I.R., and Vile, R.G. (1996). Expression of co-stimulatory molecules by tumor cells decreases tumorigenicity but may also reduce systemic antitumor immunity. Hum. Gene Ther. 7, 1771-1779.
6. Chong, H., Todryk, S., Hutchinson, G., Hart, I.R., and Vile, R.G. (1998). Tumour cell expression of B7 costimulatory molecules and interleukin-12 or granulocyte-macrophage colony stimulating factor induces a local antitumour response and may generate systemic protective immunity. Gene Ther. 5, 223-232.
7. Colombo, M., and Forni, G. (1994). Cytokine gene transfer in tumor inhibition and tumor therapy: Where are we now? Immunol. Today 15, 48-51.
8. Coughlin, C.M., Wysocka, M., Kurzawa, H.L., Lee, W.M., Trinchieri, G., and Eck, S.L. (1995). B7-1 and interleukin-12 synergistically induce effective antitumor immunity. Cancer Res. 55, 4980-4987.
9. Fujiwara, H., Clark, S.C., and Hamaoka, T. (1996). Cellular and molecular mechanisms underlying IL-12-induced tumor regression. Ann. N.Y. Acad. Sci. 795, 294-309.
10. Galea-Lauri, J., Farzaneh, F., and Gäken, J. (1996). Novel costimulators in the immune gene therapy of cancer. Cancer Gene Ther. 3, 202-214.
11. Kubin, M., Kamoun, M., and Trinchieri, G. (1994). Interleukin-12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J. Exp. Med. 180, 211-222.
12. Lenschow, D.J., Walunas, T.L., and Bluestone, J.A. (1996). CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14, 233-258.
13. + lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma. J. Immunol. 153, 421-428.
14. Miller, A.D., and Rosman, G.J. (1989). Improved retroviral vectors for gene transfer and expression. BioTechniques 7, 980-990.
15. Mu, J., Zou, J.P., Yamamoto, N., Tsutsui, T., Tai, X.G., Kobayashi, M., Herrmann, S., Fujiwara, H., and Hamaoka, T. (1995). Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes. Cancer Res. 55, 4404-4408.
16. Murphy, E.E., Terres, G., Macatonia, S.E., Hsieh, C.S., Mattson, J., Lanier, L., Wysocka, M., Trinchieri, G., Murphy, K., and O'Garra, A. (1994). B7 and interleukin-12 cooperate for proliferation and interferon-γ production by mouse T helper clones that are unresponsive to B7 costimulation. J. Exp. Med. 180, 223-231.
17. Musiani, P., Modesti, A., Giovarella, M., Cavallo, F., Colombo, M., Lollini, P., and Forni, G. (1997). Cytokine, tumor-cell death and immunogenicity: A question of choice. Immunol. Today 18, 32-36.
18. Nastala, C.L., Edington, H.D., McKinney, T.G., Tahara, H., Nalesnik, M.A., Brunda, M.J., Gately, M.K., Wolf, S.F., Schreiber, R.D., Storkus, W.J., and Lotze, M.T. (1994). Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J. Immunol. 153, 1697-1706.
19. Pericle, F., Giovarelli, M., Colombo, M.P., Ferrari, G., Musiani, P., Modesti, A., Gavallo, F., Di-Pierro, F., Novelli, F., and Forni, G. (1994). An efficient Th-2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4. J. Immunol. 153, 5659-5673.
20. Pizzoferrato, E., Chu, N.R., Hawley, T.S., Lieu, F.H.L., Barber, B.H., Hawley, R.G., Watts, T.H., and Berinstein, N.L. (1997). Enhanced immunogenicity of B cell lymphoma genetically engineered to express both B7-1 and interleukin-12. Hum. Gene Ther. 8, 2217-2228.
21. Ramarathinam, L., Castle, M., Wu, Y., and Liu, Y. (1994). T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: An important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells. J. Exp. Med. 179, 1205-1214.
22. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd Ed. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
23. Schmidt-Wolf, G.D., and Schmidt-Wolf, I.G.H. (1995). Cytokines and gene therapy. Immunol. Today 16, 173-175.
24. Schwartz, R.H. (1990). A cell culture model for T lymphocyte clonal anergy. Science 248, 1349-1356.
25. Sgadari, C., Angiolillo, A.L., and Tosato, G. (1996). Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10. Blood 87, 3877-3882.
26. Shurin, M.R., Esche, C., Peron, J.M., and Lotze, M.T. (1997). Antitumor activities of IL-12 and mechanisms of action. Chem. Immunol. 68, 153-174.
27. Stern, A.S., Magram, J., and Presky, D.H. (1996). Interleukin-12, an integral cytokine in the immune response. Life Sci. 58, 639-654.
28. Tahara, H., Zitvogel, L., Storkus, W.J., Zeh, H.J., III, McKinney, T.G., Schreiber, R.D., and Gubler, U. (1995). Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J. Immunol. 154, 6466-6474.
29. Tannenbaum, C.S., Wicker, N., Armstrong, D., Tubbs, R., Finke, J., Bukowski, R., and Hamilton, T.A. (1996). Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12. J. Immunol. 156, 693-699.
30. + T cells by B7-transfected melanoma cells. Science 259, 368-370.
31. Townsend, S.E., Su, F.W., Atherton, J.M., and Allison, J.P. (1994). Specificity and longevity of antitumor immune responses induced by B7-transfected tumors. Cancer Res. 54, 6477-6483.
32. Trinchieri, G.(1995a). Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13, 251-276.
33. Trinchieri, G. (1995b). Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84, 4008-4027.
34. Vagliani, M., Rodolfo, M., Cavallo, F., Parenza, M., Melani, C., Parmiani, G., Forni, G., and Golombo, M.P. (1996). Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells. Cancer Res. 56, 467-470.
35. Zier, K., Gansbacher, B., and Salvadori, S. (1996). Preventing abnormalities in signal transduction of T cells in cancer: The promise of cytokine gene therapy. Immunol. Today 17, 39-45.
36. Zitvogel, L., Tahara, H., Robbins, P.D., Storkus, W.J., Clarke, M.R., Nalesnik, M.A., and Lotze, M.T. (1995). Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts. J. Immunol. 155, 1393-1403.
37. Zitvogel, L., Robbins, P.D., Storkus, W.J., Clarke, M.R., Maeurer, M.J., Campbell, R.L., Davis, C.G., Tahara, H., Schreiber, R.D., and Lotze, M.T. (1996). Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors. Eur. J. Immunol. 26, 1335-1341.